These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 24965778

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria.
    Blanc AL, Keswani T, Gorgette O, Bandeira A, Malissen B, Cazenave PA, Pied S.
    Infect Immun; 2016 Jan; 84(1):329-38. PubMed ID: 26553468
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Attenuated T Cell Responses Are Associated With the Blockade of Cerebral Malaria Development by YOP1-Deficient Plasmodium berghei ANKA.
    Hai L, Shi X, Wang Q.
    Front Immunol; 2021 Jan; 12():642585. PubMed ID: 34025654
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Gamma Interferon Mediates Experimental Cerebral Malaria by Signaling within Both the Hematopoietic and Nonhematopoietic Compartments.
    Villegas-Mendez A, Strangward P, Shaw TN, Rajkovic I, Tosevski V, Forman R, Muller W, Couper KN.
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28874445
    [Abstract] [Full Text] [Related]

  • 47. Memory CD8+ T cells exhibit tissue imprinting and non-stable exposure-dependent reactivation characteristics following blood-stage Plasmodium berghei ANKA infections.
    Shaw TN, Haley MJ, Dookie RS, Godfrey JJ, Cheeseman AJ, Strangward P, Zeef LAH, Villegas-Mendez A, Couper KN.
    Immunology; 2021 Dec; 164(4):737-753. PubMed ID: 34407221
    [Abstract] [Full Text] [Related]

  • 48. Development of a Novel CD4+ TCR Transgenic Line That Reveals a Dominant Role for CD8+ Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria.
    Fernandez-Ruiz D, Lau LS, Ghazanfari N, Jones CM, Ng WY, Davey GM, Berthold D, Holz L, Kato Y, Enders MH, Bayarsaikhan G, Hendriks SH, Lansink LIM, Engel JA, Soon MSF, James KR, Cozijnsen A, Mollard V, Uboldi AD, Tonkin CJ, de Koning-Ward TF, Gilson PR, Kaisho T, Haque A, Crabb BS, Carbone FR, McFadden GI, Heath WR.
    J Immunol; 2017 Dec 15; 199(12):4165-4179. PubMed ID: 29084838
    [Abstract] [Full Text] [Related]

  • 49. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
    Blank J, Behrends J, Jacobs T, Schneider BE.
    Infect Immun; 2016 Feb 15; 84(2):502-10. PubMed ID: 26644378
    [Abstract] [Full Text] [Related]

  • 50. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection.
    Apoorv TS, Babu PP.
    Cytokine; 2017 Feb 15; 90():113-123. PubMed ID: 27865203
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
    Howland SW, Poh CM, Gun SY, Claser C, Malleret B, Shastri N, Ginhoux F, Grotenbreg GM, Rénia L.
    EMBO Mol Med; 2013 Jul 15; 5(7):984-99. PubMed ID: 23681698
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection.
    Edwards CL, Best SE, Gun SY, Claser C, James KR, de Oca MM, Sebina I, Rivera Fde L, Amante FH, Hertzog PJ, Engwerda CR, Renia L, Haque A.
    Eur J Immunol; 2015 Jan 15; 45(1):130-41. PubMed ID: 25319247
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Neutrophils play a critical role in the pathogenesis of experimental cerebral malaria.
    Chen L, Zhang Z, Sendo F.
    Clin Exp Immunol; 2000 Apr 15; 120(1):125-33. PubMed ID: 10759773
    [Abstract] [Full Text] [Related]

  • 59. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria.
    Lepenies B, Pfeffer K, Hurchla MA, Murphy TL, Murphy KM, Oetzel J, Fleischer B, Jacobs T.
    J Immunol; 2007 Sep 15; 179(6):4093-100. PubMed ID: 17785848
    [Abstract] [Full Text] [Related]

  • 60. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
    Brant F, Miranda AS, Esper L, Gualdrón-López M, Cisalpino D, de Souza DDG, Rachid MA, Tanowitz HB, Teixeira MM, Teixeira AL, Machado FS.
    Brain Behav Immun; 2016 May 15; 54():73-85. PubMed ID: 26765997
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.